Your browser doesn't support javascript.
loading
TP53 mutants and non-HPV16/18 genotypes are poor prognostic factors for concurrent chemoradiotherapy in locally advanced cervical cancer.
Kuno, Ikumi; Takayanagi, Daisuke; Asami, Yuka; Murakami, Naoya; Matsuda, Maiko; Shimada, Yoko; Hirose, Sou; Kato, Mayumi Kobayashi; Komatsu, Masaaki; Hamamoto, Ryuji; Okuma, Kae; Kohno, Takashi; Itami, Jun; Yoshida, Hiroshi; Shiraishi, Kouya; Kato, Tomoyasu.
Afiliação
  • Kuno I; Department of Gynecology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Takayanagi D; Division of Genome Biology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Asami Y; Division of Genome Biology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Murakami N; Division of Genome Biology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Matsuda M; Department of Radiation Oncology, National Cancer Center Hospital, Tokyo, 104-0045, Japan.
  • Shimada Y; Division of Genome Biology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Hirose S; Division of Genome Biology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Kato MK; Division of Genome Biology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Komatsu M; Department of Gynecology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Hamamoto R; Division of Genome Biology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Okuma K; Division of Medical AI Research and Development, National Cancer Center Research Institute, Tokyo, Japan.
  • Kohno T; RIKEN Center for Advanced Intelligence Project, Cancer Translational Research Team, Tokyo, Japan.
  • Itami J; Division of Medical AI Research and Development, National Cancer Center Research Institute, Tokyo, Japan.
  • Yoshida H; RIKEN Center for Advanced Intelligence Project, Cancer Translational Research Team, Tokyo, Japan.
  • Shiraishi K; Department of Radiation Oncology, National Cancer Center Hospital, Tokyo, 104-0045, Japan.
  • Kato T; Division of Genome Biology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Sci Rep ; 11(1): 19261, 2021 09 28.
Article em En | MEDLINE | ID: mdl-34584128
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero / Proteína Supressora de Tumor p53 / Infecções por Papillomavirus / Alphapapillomavirus / Quimiorradioterapia Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero / Proteína Supressora de Tumor p53 / Infecções por Papillomavirus / Alphapapillomavirus / Quimiorradioterapia Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article